Sign In
Buy VNRX
$2.08
-0.240 (-10.34%)
At Close: Jun 03, 2026
Volition Solves Liquid Biopsy's "Needle in a Haystack" Problem; Achieves 180-fold (18,000%) Enrichment
09:00am, Thursday, 11'th Dec 2025
HENDERSON, Nev. , Dec. 11, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announces preprint availability of a new manuscript entitle
Volition Announces Two Abstracts were Presented at the North America Conference on Lung Cancer
09:00am, Monday, 08'th Dec 2025
HENDERSON, Nev.,, December 8, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announces the presentation of two abstracts at the North
HENDERSON, Nev. , Dec. 4, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces the inclusion of its Nu.Q® NETs H3.1 assay
HENDERSON, Nev. , Nov. 25, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces the first sale of its Nu.Q® Cancer assays
VolitionRx Limited (VNRX) Q3 2025 Earnings Call Transcript
12:51pm, Friday, 14'th Nov 2025
VolitionRx Limited ( VNRX ) Q3 2025 Earnings Call November 14, 2025 8:30 AM EST Company Participants Louise Batchelor Day - Group Chief Marketing & Communications Officer Cameron Reynolds - Founder, C
VolitionRx Limited Announces Third Quarter 2025 Financial Results and Business Update
04:10pm, Thursday, 13'th Nov 2025
Conference call to discuss financial and operational results scheduled for Friday, November 14 at 8:30 a.m. U.S. Eastern Time HENDERSON, Nevada , Nov. 13, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE
VolitionRx Limited Schedules Third Quarter 2025 Earnings Conference Call and Business Update
08:45am, Monday, 10'th Nov 2025
Conference call to take place on Friday, November 14 at 8:30 a.m. U.S. Eastern Time HENDERSON, Nev.
Volition Donates Nu.Q® Vet Cancer Tests to HOPE Animal-Assisted Crisis Response Dogs
08:00am, Friday, 17'th Oct 2025
HENDERSON, Nev. , Oct. 17, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), and its subsidiary, Volition Veterinary Diagnostics Development LLC, in line with their corporate
VolitionRx Limited Announces Pricing of $6.0 Million Underwritten Public Offering of Common Stock and Common Stock Warrants
08:30am, Friday, 10'th Oct 2025
HENDERSON, Nev. , Oct. 10, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition" or the "Company"), a multi-national epigenetics company, announced today the pricing of an underwri
VolitionRx Limited Announces Proposed Underwritten Public Offering of Common Stock and Common Stock Warrants
04:05pm, Thursday, 09'th Oct 2025
HENDERSON, Nev. , Oct. 9, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition" or the "Company"), a multi-national epigenetics company, announced today that it is proposing to off
VolitionRx Limited - Special Call
04:56pm, Wednesday, 08'th Oct 2025
VolitionRx Limited - Special Call Company Participants Marielle Herzog Conference Call Participants Alexandra Byrne Eric Ariazi Presentation Alexandra Byrne Great. Good morning, everyone.
Volition Sponsors Upcoming GenomeWeb Webinar
08:45am, Thursday, 02'nd Oct 2025
HENDERSON, Nev. , Oct. 2, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces the sponsorship of a GenomeWeb webinar entit
Volition Signs Co-Marketing and Services Agreement with Hologic
09:30am, Monday, 29'th Sep 2025
HENDERSON, Nev. , Sept. 29, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces that it has signed an agreement with Holog
VolitionRx Limited (VNRX) Q2 2025 Earnings Call Transcript
02:24pm, Friday, 15'th Aug 2025
VolitionRx Limited (NYSE:VNRX ) Q2 2025 Earnings Conference Call August 15, 2025 8:30 AM ET Company Participants Andrew Retter - Chief Medical Officer Cameron Reynolds - Founder, CEO, President & Dire
VolitionRx Limited Announces Second Quarter 2025 Financial Results and Business Update
04:10pm, Thursday, 14'th Aug 2025
Conference call to discuss financial and operational results scheduled for Friday, August 15 at 8:30 a.m. U.S. Eastern Time HENDERSON, Nev.
